Tag Archives: IOVA

H.C. Wainwright Thinks Iovance Biotherapeutics Inc’s Stock is Going to Recover

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Iovance Biotherapeutics Inc (IOVA – Research Report), with a price target of $26. The company’s shares closed on Friday at $8.97, close to its 52-week

B.Riley FBR Thinks Iovance Biotherapeutics Inc’s Stock is Going to Recover

In a report released today, Madhu Kumar from B.Riley FBR reiterated a Buy rating on Iovance Biotherapeutics Inc (IOVA – Research Report), with a price target of $24. The company’s shares closed yesterday at $8.80, close to its 52-week low

Iovance Biotherapeutics Inc (IOVA) Gets a Buy Rating from Cowen & Co.

In a report released today, Boris Peaker from Cowen & Co. maintained a Buy rating on Iovance Biotherapeutics Inc (IOVA – Research Report). The company’s shares opened today at $8.80, close to its 52-week low of $7.13. According to TipRanks.com,

H.C. Wainwright Sticks to Their Buy Rating for Iovance Biotherapeutics Inc (IOVA)

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Iovance Biotherapeutics Inc (NASDAQ: IOVA) today and set a price target of $26. The company’s shares opened today at $11.23. Pantginis wrote: “Valuation and impediments to achieving price target. We

Iovance Biotherapeutics Inc (IOVA) Received its Third Buy in a Row

After B.Riley FBR and Oppenheimer gave Iovance Biotherapeutics Inc (NASDAQ: IOVA) a Buy rating last month, the company received another Buy, this time from Chardan Capital. Analyst Gbola Amusa reiterated a Buy rating on Iovance Biotherapeutics Inc today and set

H.C. Wainwright Remains a Buy on Iovance Biotherapeutics Inc (IOVA)

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Iovance Biotherapeutics Inc (NASDAQ: IOVA) today and set a price target of $22. The company’s shares closed yesterday at $13.15. Pantginis observed: “Valuation and impediments to achieving price target. We